Access to Medicines Foundation
As Executive Director, Dr Jayasree K. Iyer leads the strategic direction and stakeholder engagement of the Access to Medicine Foundation. She directs the research programmes for the Antimicrobial Resistance Benchmark, the Access to Medicine Index, the Access to Vaccines Index and specific studies into priority health topics, such as the recently-published ”Improving access to cancer care” report. To stimulate positive change within the pharmaceutical industry, Jayasree often speaks publicly on access-to-medicine matters on platforms hosted by international, governmental and non-governmental organizations, including the UN and WHO. In this capacity, she also engages with key pharmaceutical industry investors to support their engagement activities with pharma companies. She often refers to the Access to Medicine Index as a “book of solutions” for pharmaceutical companies working to improve their access footprints. Jayasree holds various postgraduate degrees (Masters and PhD) from Singapore and the John Hopkins School of Hygiene and Public Health. She has written many technical and research reports, book chapters and reviews, along with strategy papers for medicines for developing countries and solutions for neglected tropical diseases. Before joining the Foundation, Jayasree spent four years managing a portfolio of more than 25 public private partnerships between the Dutch government and the pharmaceutical industry, totalling a research budget of €150 million. These partnerships addressed cancer, immunology and neglected diseases. She has worked for various non-government organisations, academic institutions and was part of the founding team of a diagnostic service company in the US.
|1 FEB, 2018||14:30-16-30 hrs.||PS1.3||Safeguarding Medicines in the Era of AMR: What Do We Know? What Works?|